13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001420506-23-000693
Total Value
$262.4M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NOVO-NORDISK A S | NONOF | 371,055 | $50.2M | 19.14% |
| 2 | LILLY ELI & CO | LLY | 104,328 | $38.2M | 14.55% |
| 3 | ARGENX SE | ARGX | 85,204 | $32.3M | 12.30% |
| 4 | MERCK & CO INC | MRK | 264,200 | $29.3M | 11.17% |
| 5 | KARUNA THERAPEUTICS INC | 48576A100 | 99,267 | $19.5M | 7.43% |
| 6 | ABBVIE INC | ABBV | 90,821 | $14.7M | 5.59% |
| 7 | MODERNA INC | MRNA | 74,719 | $13.4M | 5.11% |
| 8 | IVERIC BIO INC | 46583P102 | 504,615 | $10.8M | 4.12% |
| 9 | BIOGEN INC | BIIB | 30,000 | $8.3M | 3.17% |
| 10 | SEAGEN INC | SE | 51,175 | $6.6M | 2.51% |
| 11 | BIONTECH SE | BNTX | 37,108 | $5.6M | 2.12% |
| 12 | NEUROCRINE BIOSCIENCES INC | NBIX | 45,000 | $5.4M | 2.05% |
| 13 | ASTRAZENECA PLC | AZN | 77,759 | $5.3M | 2.01% |
| 14 | ALNYLAM PHARMACEUTICALS INC | ALNY | 15,971 | $3.8M | 1.45% |
| 15 | BIOMARIN PHARMACEUTICAL INC | BMRN | 28,217 | $2.9M | 1.11% |
| 16 | THERMO FISHER SCIENTIFIC INC | TMO | 5,088 | $2.8M | 1.07% |
| 17 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 22,321 | $2.5M | 0.94% |
| 18 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 41,600 | $2.2M | 0.84% |
| 19 | VERTEX PHARMACEUTICALS INC | VRTX | 7,114 | $2.1M | 0.78% |
| 20 | MODERNA INC | MRNA | 10,000 | $1.8M | 0.68% |
| 21 | VIKING THERAPEUTICS INC | VKTX | 130,913 | $1.2M | 0.47% |
| 22 | VERONA PHARMA PLC | 925050106 | 39,951 | $1.0M | 0.40% |
| 23 | WATERS CORP | 941848103 | 2,845 | $974,640 | 0.37% |
| 24 | AMYLYX PHARMACEUTICALS INC | AMLX | 23,883 | $882,477 | 0.34% |
| 25 | KYMERA THERAPEUTICS INC | KYMR | 30,000 | $748,800 | 0.29% |